|
Capnography Study:
|
|
Overview:
A study designed to determine if there
is significance between clinical events occuring during a procedural
sedation and End Tidal levels
|
|
Study Endpoints:
ETCO2 levels drawn as measured with the CapnoStream20 monitor.
Clinical events as they occur throughout the procedure. |
|
Eligible Patients:
18 or older; Receiving a conscious sedation for any reason. Any patient
is eligible as long as they do not randomize to Ketamine. If the Dr.
does not wish to randomize the patient to the other sedation studies,
the patient can still be eligible for this one.
|
|
Study Design:
Prospective, observational trial
|
|
Anticipated
Benefits: None
|
|
Potential Risks:
None
|
|
Research Associate’s
Role: Identify and consent potential patients. Obtain End Tidal
levels with ETCO2 monitor; The RA is responsible for identifying,
enrolling, and collecting data from eligible patients for this study.
The RA is in charge of setting up and putting away the End-Tidal CO2
monitors used to obtain data.
Also, instructions for how to use the new
End Tidal monitor are taped to the BIS cart, and also above the center
computer in the media room. Cannulae for the new monitor are on a shelf
in the media room.
Please only use the new monitor for sedations if you get a patient in
this particular study, or combine it with either the Alfentanil or
Ketamine studies (assuming patient does not randomize to Ketamine).
|
|
Physician’s Role:
The RA will ask you to notify them of any conscious sedations being
performed so that they may enter the patient into the study.
|
|
Location of Study
Packets: Team Center B (center island). Consents and datasheets are
paper-clipped together.
|
